BridgeBio Pharma, Inc. (BBIO) Social Stream



BridgeBio Pharma, Inc. (BBIO): $48.57

-1.33 (-2.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BridgeBio Pharma Inc (BBIO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BBIO.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
10 $91 $66 $80.4 $48.73 64.99%

The Trend in the Analyst Price Target


Over the past 16 months, BBIO's average price target has gone up $35.5.

BBIO reports an average of 26.04% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 10 91 66 80.40 50.35 59.68%
2021-09-04 9 91 66 80.44 51.62 55.83%
2021-08-28 8 91 66 80.88 50.48 60.22%
2021-08-14 8 91 66 80.88 50.12 61.37%
2021-08-07 8 91 66 80.88 54.10 49.5%
2021-08-05 8 91 71 81.63 56.13 45.43%
2021-08-01 8 91 71 81.63 53.45 52.72%
2021-07-24 8 91 71 81.63 60.60 34.7%
2021-07-17 8 91 71 81.63 59.18 37.94%
2021-07-10 8 91 71 81.63 64.17 27.21%
2021-07-03 8 91 71 81.63 63.85 27.85%
2021-06-26 8 91 71 81.63 60.45 35.04%
2021-06-13 8 91 71 81.63 63.93 27.69%
2021-06-05 8 91 71 81.63 57.96 40.84%
2021-05-22 8 91 71 81.63 57.90 40.98%
2021-05-15 8 91 71 81.63 53.66 52.12%
2021-05-08 8 92 71 83.13 48.03 73.08%
2021-04-25 8 92 75 84.25 54.47 54.67%
2021-04-17 8 91 75 84.13 55.12 52.63%
2021-04-10 9 91 75 84.22 54.49 54.56%
2021-04-03 9 91 75 84.22 59.36 41.88%
2021-03-20 9 91 67 81.67 67.66 20.71%
2021-03-13 9 91 67 81.67 70.94 15.13%
2021-03-06 9 91 67 81.67 62.22 31.26%
2021-02-27 9 91 56 78.33 70.68 10.82%
2021-02-20 9 91 50 71.22 66.68 6.81%
2021-02-13 9 91 50 71.22 67.36 5.73%
2021-02-06 8 91 50 69.75 68.28 2.15%
2021-01-30 8 91 50 69.75 56.76 22.89%
2021-01-23 8 91 44 63.75 69.48 -8.25%
2021-01-16 8 91 44 63.75 68.61 -7.08%
2021-01-09 8 91 44 60.88 65.51 -7.07%
2021-01-02 9 91 44 56.11 71.11 -21.09%
2020-12-26 9 91 44 56.11 69.50 -19.27%
2020-12-19 9 91 44 56.11 64.89 -13.53%
2020-12-10 9 60 44 50.22 57.75 -13.04%
2020-12-07 9 60 44 50.22 53.10 -5.42%
2020-11-28 9 60 39 49.11 49.13 -0.04%
2020-11-11 9 60 39 49.11 40.97 19.87%
2020-10-09 9 53 39 46.78 39.34 18.91%
2020-09-29 11 52 38 45.27 37.10 22.02%
2020-08-11 11 51 38 44.45 NA NA%
2020-07-28 11 51 38 44.27 NA NA%
2020-07-22 11 51 38 44.27 NA NA%
2020-06-25 11 51 38 44.27 NA NA%
2020-05-29 10 51 39 44.90 NA NA%

BBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.28 4 5 0 0 0 9

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The average analyst price target of BBIO is higher than 90.21% of Pharmaceutical Products stocks.
  • The upside potential (average analyst target price relative to current price) of BBIO is greater than 87.06% of stocks in the mid market cap category.
  • The number of analysts covering the stock of BBIO is greater than 86.15% of Pharmaceutical Products stocks.
  • BridgeBio Pharma Inc's variance in analysts' estimates is less than 64.06% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, REPL, IGMS and ITCI are the three stocks most similar to BridgeBio Pharma Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding BBIO using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9459 seconds.